Absence of influence of prior interferon alfa (IFN alpha) therapy on the outcome of allogeneic bone marrow transplantation (BMT) for chronic myelogenous leukemia (CML).

被引：0
|
作者：
Tomas, IF [1 ]
Steegman, IL [1 ]
Requena, MI [1 ]
Soria, VGG [1 ]
FernandezRanada, IM [1 ]
机构：
[1] UNIV MADRID,HOSP PRINCESA,DEPT HAEMATOL,MADRID,SPAIN
来源：
BLOOD | 1995年 / 86卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3859 / 3859
页数：1
相关论文
共 50 条
  • [1] EFFECT OF PRIOR INTERFERON-ALFA THERAPY ON THE OUTCOME OF ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA
    GIRALT, SA
    KANTARJIAN, HM
    TALPAZ, M
    RIOS, MB
    DELGIGLIO, A
    ANDERSSON, BS
    PRZEPIORKA, D
    DEISSEROTH, AB
    CHAMPLIN, RE
    JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (06) : 1055 - 1061
  • [2] Absence of influence of prior treatment with interferon on the outcome of allogeneic bone marrow transplantation for chronic myeloid leukemia
    JF Tomás
    JL López-Lorenzo
    MJ Requena
    R Aguilar
    JL Steegmann
    R Cámara
    A Alegre
    R Arranz
    A Figuera
    JM Fernández-Rañada
    Bone Marrow Transplantation, 1998, 22 : 47 - 51
  • [3] Absence of influence of prior treatment with interferon on the outcome of allogeneic bone marrow transplantation for chronic myeloid leukemia
    Tomás, JF
    López-Lorenzo, JL
    Requena, MJ
    Aguilar, R
    Steegmann, JL
    Cámara, R
    Alegre, A
    Arranz, R
    Figuera, A
    Fernández-Rañada, JM
    BONE MARROW TRANSPLANTATION, 1998, 22 (01) : 47 - 51
  • [4] Adjuvant treatment with alfa interferon (IFN) for patients at high risk for relapse after allogeneic bone marrow transplantation (BMT) for chronic myelogenous leukemia (CML): A preliminary report.
    Higano, C
    Chielens, D
    Radich, J
    Flowers, M
    Appelbaum, F
    BLOOD, 1998, 92 (10) : 654A - 654A
  • [5] Improved survival of patients with chronic myelogenous leukemia (CML) undergoing allogeneic bone marrow transplantation (BMT).
    Moreb, J
    Johnson, T
    Kubilis, P
    Myers, L
    BLOOD, 1995, 86 (10) : 3826 - 3826
  • [6] Adjuvant Treatment with Alpha Interferon (IFN) for Patients at High Risk for Relapse after Allogeneic Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)
    Bezerra, Evandro Dantas
    Radich, Jerald
    Flowers, Mary E.
    Chielins, Debbie
    Higano, Celestia
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S238 - S238
  • [7] Effect of interferon-alpha (IFN-A) therapy on bone marrow (BM) fibrosis in chronic myelogenous leukemia (CML)
    Wilhelm, M
    Ramos, CM
    OBrien, S
    Pierce, S
    Keating, M
    Talpaz, M
    Kantarjian, H
    BLOOD, 1996, 88 (10) : 3537 - 3537
  • [8] ALLOGENEIC MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA (CML)
    BUCKNER, CD
    CLIFT, RA
    STORB, R
    THOMAS, ED
    EXPERIMENTAL HEMATOLOGY, 1986, 14 (06) : 486 - 486
  • [9] BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC MYELOGENOUS LEUKEMIA (CML) - A MULTIINSTITUTIONAL STUDY
    ELFENBEIN, G
    WEINER, R
    WINTON, E
    VOGLER, R
    LAZARUS, H
    STEWART, M
    FLAUM, M
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 206 - 206
  • [10] ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA (CML)
    CHAMPLIN, R
    GALE, RP
    EXPERIMENTAL HEMATOLOGY, 1982, 10 : 19 - 19
12345